A Closed Perfusion System with Heparin Coating and Centrifugal Pump Improves Cardiopulmonary Bypass Biocompatibility in Elderly Patients
Overview
Pulmonary Medicine
Affiliations
Background: Cardiopulmonary bypass induces a systemic inflammatory and hemostatic activation, which may contribute to postoperative complications. Our aim was to compare the inflammatory response, coagulation, and fibrinolytic activation between two different perfusion systems: one theoretically more biocompatible with a closed-circuit, complete heparin coating, and a centrifugal pump, and one conventional system with uncoated circuit, roller pump, and a hard-shell venous reservoir.
Methods: Forty-one elderly patients (mean age, 73 +/- 1 years, 66% men) undergoing coronary artery bypass grafting or aortic valve replacement were included in a prospective, randomized study. Plasma concentrations of complement factors (C3a, C4d, Bb, and sC5b-9), proinflammatory cytokines (tumor necrosis factor-alpha, interleukin-6, and interleukin-8), granulocyte degradation products (polymorphonuclear elastase), and markers of coagulation (thrombin-antithrombin) and fibrinolysis (D-dimer, tissue plasminogen activator antigen and tissue plasminogen activator-plasminogen activator inhibitor-1 complex) were measured preoperatively, at bypass during rewarming (35 degrees C), 60 minutes after bypass, and on day 1 after surgery.
Results: The mean concentrations of C3a (-39%; p = 0.008), Bb (-38%; p < 0.001), sC5b-9 (-70%; p < 0.001), interleukin-8 (-60%; p = 0.009), polymorphonuclear-elastase (-55%; p < 0.003), and tissue plasminogen activator antigen (-51%; p = 0.012) were all significantly lower in the biocompatible group during rewarming. Sixty minutes after bypass, the mean concentrations of sC5b-9 (-39%; p = 0.006) and polymorphonuclear-elastase (-55%; p < 0.001) were lower in the biocompatible group.
Conclusions: The results suggest that a closed perfusion system with a heparin-coated circuit and a centrifugal pump may improve cardiopulmonary bypass biocompatibility in elderly cardiac surgery patients in comparison with a conventional system.
2024 EACTS/EACTAIC/EBCP Guidelines on cardiopulmonary bypass in adult cardiac surgery.
Wahba A, Kunst G, De Somer F, Kildahl H, Milne B, Kjellberg G Eur J Cardiothorac Surg. 2025; 67(2).
PMID: 39949326 PMC: 11826095. DOI: 10.1093/ejcts/ezae354.
2024 EACTS/EACTAIC/EBCP Guidelines on cardiopulmonary bypass in adult cardiac surgery.
Wahba A, Kunst G, De Somer F, Kildahl H, Milne B, Kjellberg G Interdiscip Cardiovasc Thorac Surg. 2025; 40(2).
PMID: 39949317 PMC: 11826094. DOI: 10.1093/icvts/ivaf002.
Neutrophils: a key component in ECMO-related acute organ injury.
Zhang M, Li S, Ying J, Qu Y Front Immunol. 2024; 15:1432018.
PMID: 39346902 PMC: 11427252. DOI: 10.3389/fimmu.2024.1432018.
Strategies to attenuate maladaptive inflammatory response associated with cardiopulmonary bypass.
Banerjee D, Feng J, Sellke F Front Surg. 2024; 11:1224068.
PMID: 39022594 PMC: 11251955. DOI: 10.3389/fsurg.2024.1224068.
Gao S, Liu G, Wang J, Zhang Q, Wang J, Teng Y Heliyon. 2024; 10(11):e31388.
PMID: 38832269 PMC: 11145224. DOI: 10.1016/j.heliyon.2024.e31388.